Keymed Biosciences Inc.

HKEX:2162.HK

31.75 (HKD) • At close December 24, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Operating Activities:
Net Income -168.373-168.373-203.162-203.16223.48423.484-156.785-156.7852.7272.727-129.405-129.405-1,814.25-1,814.25-391.549-391.549-17.743-17.743
Depreciation & Amortization 23.16823.16821.17821.08213.30613.30610.51810.5187.3767.3765.245.245.2315.2315.2525.2524.2354.235
Deferred Income Tax 0000-96.8414.277-61.038-9.424-2.799000000000
Stock Based Compensation 8.8178.81712.19812.1987.8427.84212.68612.68611.59811.5988.6578.65749.75549.7550000
Change In Working Capital -29.206-29.2067.7197.719-3.794-3.79443.34543.345-52.244-52.24418.92618.926-13.695-13.69518.96618.966-24.179-24.179
Accounts Receivables 7.1477.147-9.395-9.395-4.151-4.151-0.3401.991.99-1.99-1.99000000
Change In Inventory -13.788-13.78812.03912.039-17.968-17.968-3.262-3.262-10.789-10.7892.0752.075-6.849-6.849-0.169-0.169-1.601-1.601
Change In Accounts Payables 000021.66205.08700000000000
Other Working Capital -22.564-22.5645.0755.07518.32518.32546.60746.607-43.445-43.44518.84118.841-6.847-6.84719.13519.135-22.578-22.578
Other Non Cash Items -17.368-17.368-9.564-9.467-21.017-21.017-28.041-28.041-52.146-52.14631.63931.6391,730.5841,730.584347.559347.559-2.221-2.221
Operating Cash Flow -182.961-182.961-171.631-171.63119.82119.821-118.278-118.278-82.689-82.689-64.944-64.944-42.375-42.375-19.773-19.773-39.908-39.908
Investing Activities:
Investments In Property Plant And Equipment -53.713-53.713-38.657-38.657-124.941-124.941-46.044-46.044-93.367-93.367-78.43-78.43-7.464-7.464-5.502-5.502-4.401-4.401
Acquisitions Net 0000-170.32079.14500000000000
Purchases Of Investments 0000-705.2680-5,614.49100000000000
Sales Maturities Of Investments 00001,503.10505,271.54400000000000
Other Investing Activites 33.78333.78350.60850.608347.091347.091-105.194-105.194-78.189-78.189-919.055-919.055-12.992-12.99252.45252.452-99.083-99.083
Investing Cash Flow -19.93-19.9311.95211.952222.15222.15-151.237-151.237-171.556-171.556-997.485-997.485-20.455-20.45546.9546.95-103.484-103.484
Financing Activities:
Debt Repayment 000000000000000000
Common Stock Issued 000000-34.23800000000000
Common Stock Repurchased -16.213-16.213-2.074-2.074-14.377-14.377-6.265-6.265-19.303-19.30300000000
Dividends Paid 000000000000000000
Other Financing Activities 148.175148.17540.10340.10312.41412.414-29.933-29.93351.47151.4711,436.5981,436.598382.591382.591-1.91-1.915.6095.609
Financing Cash Flow 131.962131.96238.02938.029-1.964-1.964-36.198-36.19832.16832.1681,436.5981,436.598382.591382.591-1.91-1.915.6095.609
Other Information:
Effect Of Forex Changes On Cash 0.370.37-10.433-10.43315.55515.55519.66919.66949.84649.846-30.665-30.665-2.661-2.661-7.132-7.1323.0483.048
Net Change In Cash -70.559-70.559-132.083-132.083524.881255.563-700.459-286.044-172.231-172.231343.505343.505317.1317.118.13618.136-134.735-134.735
Cash At End Of Period -70.559-70.559-132.083-132.0831,203.094255.563678.213890.1141,176.157-172.231343.5051,177.114833.609317.118.136181.274163.138-134.735